David started his career as a graduate engineer in Carnaud Metalbox (now Crown Cork), working in a range of roles from R&D to production and project management. David spent much of his career living and working overseas in Spain, Argentina, Belgium and France. David did his MBA at Harvard Business School, after which he joined Z Corporation, an MIT licensee start up. He spent several years growing the European and Asian businesses before entering the venture industry. David predominantly focuses on physical science and engineering opportunities.
Matthew has a D.Phil in Biochemistry from the University of Oxford. His pre-venture experience ranges from working in clinical pathology to virology with Zeneca and drug development with Neures. Matthew began venture investing in 1999 and has worked with several investee companies either as an interim manager or board director. Matthew predominantly focuses on life science opportunities.
Michael has a D.Phil in Mathematics from the University of Oxford. He subsequently spent 16 years at Morgan Stanley as an investment banker, in the last few years advising private equity houses on leveraged buy-outs, IPOs and trade sales. In 2001 he was asked to support the turnaround of a listed media company as interim Finance Director. Michael subsequently invested and worked on the turnaround of a small Australian public company in the security industry, resulting in the sale of the business to a US buyer. Michael has also made a significant number of angel investments in early stage technology businesses in the UK and until 2014 was Chairman of NaturalMotion, an Oxford-based start up in the mobile games industry which was sold to Zynga for $527m. Michael predominantly focuses on applications of physical sciences and mathematics in areas such as security, media and business software.
Jane is a Chartered Accountant who trained with PricewaterhouseCoopers in their Bristol office before leaving in 2000 to join the group finance team at Future plc, a listed media company. At Future Jane worked on a number of transactions including a rights issue in 2001 before becoming Group Financial Controller. In 2006 she joined Eden Ventures, an early stage venture capital investor in software startups as Financial Controller. She spent much of her time providing support to the portfolio of Eden investments particularly around financial reporting, forecasting & fundraising and equity incentives as well as internal financial control for the Eden funds. Jane joined Longwall in November 2012 as CFO.
Rebecca began venture investing in 2006 while at Oxford Capital, where she took responsibility for the Oxford Gateway Funds’ investments into healthcare and life science companies, and went on to become Director, Healthcare Ventures at Imperial Innovations (now Touchstone Innovations). Her earlier career was as a marketing consultant to pharmaceutical and life science technology companies. Rebecca has a PhD in Genetics from Nottingham University and an MBA from Oxford University. She joins Longwall Ventures after a couple of years sabbatical break spent exploring South America in a VW camper van and will predominantly focus on medical technology opportunities.